Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2

BACKGROUND: A reduction in renal angiomyolipoma volume observed with everolimus (EVE) treatment in patients with tuberous sclerosis complex (TSC) has been postulated to translate to clinical benefit by reducing the risk of renal hemorrhage and chronic renal failure. METHODS: The long-term effects of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nephrol Dial Transplant
Auteurs principaux: Bissler, John J, Budde, Klemens, Sauter, Matthias, Franz, David N, Zonnenberg, Bernard A, Frost, Michael D, Belousova, Elena, Berkowitz, Noah, Ridolfi, Antonia, Christopher Kingswood, J
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
ORIGINAL ARTICLES
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545468/
https://ncbi.nlm.nih.gov/pubmed/30053159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy132
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires